tag modelling 
STAT
JANUARY 30, 2024
In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. government on Tuesday announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments. million and $3.1
STAT
JANUARY 31, 2024
In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. government announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments , STAT says.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
MAY 24, 2023
Individual value is what drives commercial models of these companies and ensures their long-term success. Notably, the focus of pharma companies never shifted from customer-centric approach, although the rise of AI technologies was probably the hottest issue of the event.
Pharmaceutical Technology
DECEMBER 15, 2022
This extrapolation leverages data from GlobalData’s World Markets Healthcare and PharmOnline International databases to expand the number of markets in GlobalData’s patient-based sales forecast model from seven major markets (7MM) to 68 markets (68M). The second highest contributing market is APAC, generating 33.2%
Pharmaceutical Technology
FEBRUARY 10, 2023
This is not the first treatment to come with a high price tag. While performance-based RSAs initially grew in popularity, ease of implementation allowed finance-based models to dominate. Countries with a high willingness for performance-based models, such as the UK, saw this RSA type peak in 2019 before continually declining.
Pharmaceutical Technology
MAY 1, 2023
CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. In animal models of ovarian cancer, it demonstrated promising results.
pharmaphorum
JANUARY 21, 2022
Flawed funding model. This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.
Expert insights. Personalized for you.
124 
Let's personalize your content